This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (51)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Review of 11 Cases

Dominique Friedmann, MD; Janine Wechsler, MD; Marie-Hélène Delfau, MD; E. Estève, MD; Jean-Pierre Farcet, MD; Anne de Muret, MD; Anne Parneix-Spake, MD; Loic Vaillant, MD; Jean Revuz, MD; Martine Bagot, MD; The French Study Group on Cutaneous Lymphomas

Arch Dermatol. 1995;131(9):1009-1015.

Abstract
Background and Design
Cutaneous pleomorphic small T-cell lymphoma is a rare, recently recognized lymphoma, different from mycosis fungoides and Sézary syndrome. Only a few cases have been reported and no treatment modalities have been defined. We reviewed the clinical, histologic, immunohistochemical, molecular biologic, and follow-up data of 11 primary cutaneous pleomorphic small T-cell lymphomas.

Results
The lesions presented as red purplish nodules, tumors, or plaques. The infiltrate consisted of small pleomorphic lymphoid cells without epidermotropism in nine patients and with a propensity to infiltrate the dermis and subcutaneous fat. Most cases were CD4⁺/CD8^-. A T-cell clone was detected in the skin lesions of nine patients tested. The mean follow-up was 70.1 months and the median follow-up was 20 months. Ten patients are alive with three having persistent lesions. Interferon alfa-2a induced partial or complete remissions in five patients. Interferon alfa-2a combined with a regimen containing doxorubicin chlorhydrate induced a complete remission in a patient suffering a relapse after cyclophosphamide and interferon alone.

Conclusions
Cutaneous pleomorphic small T-cell lymphoma is a well-defined type of low-grade cutaneous lymphoma with favorable prognosis. Interferon and/or chemotherapy are the treatment of choice in patients with large tumor burden.

(Arch Dermatol. 1995;131:1009-1015)

Author Affiliations
From the Departments of Dermatology (Drs Friedmann, Parneix-Spake, Revuz, and Bagot), Pathology (Dr Wechsler), and Immunology (Drs Delfau and Farcet), Henri-Mondor Hospital, Creteil, and the Departments of Dermatology (Drs Estève and Vaillant) and Pathology (Dr de Muret), Trousseau Hospital, Tours, France. A complete list of members of The French Study Group on Cutaneous Lymphomas appears on page 1014.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Primary Cutaneous Small/Medium CD4+ T-Cell Lymphomas: A Heterogeneous Group of Tumors With Different Clinicopathologic Features and Outcome
Garcia-Herrera et al.
JCO 2008;26:3364-3371.
ABSTRACT | FULL TEXT  

Cutaneous Lymphoid Hyperplasia Presenting as a Solitary Facial Nodule: Clinical, Histopathological, Immunophenotypical, and Molecular Studies
Bergman et al.
Arch Dermatol 2006;142:1561-1566.
ABSTRACT | FULL TEXT  

WHO-EORTC classification for cutaneous lymphomas
Willemze et al.
Blood 2005;105:3768-3785.
ABSTRACT | FULL TEXT  

Prognostic Factors in Primary Cutaneous Lymphomas Other Than Mycosis Fungoides and the Sezary Syndrome
Grange et al.
Blood 1999;93:3637-3642.
ABSTRACT | FULL TEXT  

Isolation of Tumor-Specific Cytotoxic CD4+ and CD4+CD8dim+ T-Cell Clones Infiltrating a Cutaneous T-Cell Lymphoma
Bagot et al.
Blood 1998;91:4331-4341.
ABSTRACT | FULL TEXT  

EORTC Classification for Primary Cutaneous Lymphomas: A Proposal From the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer
Willemze et al.
Blood 1997;90:354-371.
ABSTRACT | FULL TEXT  

New Concepts in the Classification of Cutaneous Lymphomas
Willemze
Arch Dermatol 1995;131:1077-1080.
ABSTRACT  

Is Cutaneous T-Cell Lymphoma Curable?
Koh et al.
Arch Dermatol 1995;131:1081-1082.
ABSTRACT